VI
ADMA icon

Vestcor Inc’s ADMA Biologics ADMA Stock Holding History

Vestcor Inc’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$178K Hold
21,326
– – ﹤0.01% 1062
2026
Q1 		$192K Hold
21,326
– – 0.01% 1037
2025
Q4 		$389K Sell
21,326
-26,796
-56% -$452K 0.01% 787
2025
Q3 		$705K Buy
48,122
+19,593
+69% +$336K 0.02% 605
2025
Q2 		$520K Buy
+28,529
New +$582K 0.02% 681

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vestcor Inc's ADMA Position: Q2 2026 in Review

Vestcor Inc held its ADMA Biologics (ADMA) position steady in Q2 2026 at 21,326 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #1062.

Vestcor Inc first reported a position in ADMA in Q2 2025 and has held it in 5 quarters since. The position peaked at $705K in Q3 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Vestcor Inc held 21,326 shares of ADMA Biologics worth $178K as of Q2 2026.
  • Vestcor Inc left its ADMA Biologics share count unchanged in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of Vestcor Inc's portfolio in Q2 2026, its #1062 holding.
  • Vestcor Inc first reported a position in ADMA Biologics in Q2 2025 and has held it in 5 quarters since.
  • Vestcor Inc's ADMA Biologics position peaked at $705K in Q3 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.